Evidence map›Paper›PMID 37623609›Full record

ArticleJournal of fungi (Basel, Switzerland)2023

Risk Factors for

Giulio Viceconte, Antonio Riccardo Buonomo, Alessia D'Agostino, Maria Foggia, Antonio Di Fusco, Biagio Pinchera, Riccardo Scotto, Carmine Iacovazzo, Luca Fanasca, Gaetana Messina and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of fungi (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Review
  2. Article
  3. Prevalence ofMicroorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Giulio ViceconteDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Antonio Riccardo BuonomoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.ORCID 0000-0002-4378-8366
Alessia D'AgostinoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Maria FoggiaDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Antonio Di FuscoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Biagio PincheraDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.ORCID 0000-0002-8685-5434
Riccardo ScottoDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.ORCID 0000-0002-0178-2986
Carmine IacovazzoDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Luca FanascaDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 8031 Naples, Italy.
Gaetana MessinaThoracic Surgery Unit, University of Campania "Luigi Vanvitelli", Via Sergio Pansini n.5, 8031 Naples, Italy.
Francesco CacciatoreDepartment of Translational Medical Sciences, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.
Paola SalvatoreDepartment of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", 8031 Naples, Italy.
Ivan GentileDepartment of Clinical Medicine and Surgery, University of Naples "Federico II", Via Sergio Pansini n.5, 8031 Naples, Italy.ORCID 0000-0002-5199-8451
On Behalf Of The Federico Ii Covid Team
University of Naples Federico II · ITUniversity of Campania "Luigi Vanvitelli" · IT

Funding

European Union NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT)Regione Campania POR Campania FESR 2014-2020 - Asse 1 - Obiettivo Specifico 1.3. - Azione 1.3.1
6 · The paper itself

Abstract

backgroundVery few cases of

methodsA retrospective case-control study was performed. We matched PJP cases with controls with a 1:2 ratio, based on age ± 10 years, solid-organ transplantation (SOT), hematological malignancies, and in the setting of PJP development (ICU vs. non-ICU). A direct immunofluorescence assay on bronchoalveolar lavage fluid was used to diagnose PJP.

resultsWe enrolled 54 patients. Among 18 cases of PJP, 16 were diagnosed as "proven". Seven of the eighteen cases were immunocompromised, while the other patients had no previous immunological impairment. Patients with PJP had significantly lower median lymphocyte values (

conclusionsPJP develops in COVID-19 patients regardless of immunosuppressive conditions and the severity of disease, and it is correlated to the corticosteroid dose received.

Indexed as

COVID-19immunocompromisedPneumocystis jiroveciipneumoniaSARS-CoV-2

Identifiers

PMID37623609
PMCPMC10455879
OpenAlexW4385761029

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.